Tokyo Tape
Sign in
← Pharmarise Holdings

Quarterly report · Q3

2796.TEDINET S100T8YK
Period2023-06-01 → 2024-02-29
Filed2024-04-10
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 36
MetricValuePeriodScopeSource row
Revenue¥40.7bn2023-06-01 → 2024-02-29Cons.Net sales
Revenue¥52.0bn2022-06-01 → 2023-05-31Cons.Net sales (5-year summary)
Revenue¥38.7bn2022-06-01 → 2023-02-28Cons.Net sales
Operating income¥863m2023-06-01 → 2024-02-29Cons.Operating income
Operating income¥896m2022-06-01 → 2023-02-28Cons.Operating income
Ordinary income¥799m2023-06-01 → 2024-02-29Cons.Ordinary income
Ordinary income¥1.4bn2022-06-01 → 2023-05-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥890m2022-06-01 → 2023-02-28Cons.Ordinary income
Profit before tax¥761m2023-06-01 → 2024-02-29Cons.Income before income taxes
Profit before tax¥722m2022-06-01 → 2023-02-28Cons.Income before income taxes
Net income (owners)¥177m2023-06-01 → 2024-02-29Cons.Profit loss attributable to owners of parent
Net income (owners)¥333m2022-06-01 → 2023-05-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥208m2022-06-01 → 2023-02-28Cons.Profit loss attributable to owners of parent
Net income¥187m2023-06-01 → 2024-02-29Cons.Profit loss
Net income¥218m2022-06-01 → 2023-02-28Cons.Profit loss
Total assets¥26.4bnat 2024-02-29Cons.Assets
Total assets¥23.4bnat 2023-05-31Cons.Assets
Total assets¥22.9bnat 2023-02-28Cons.Total assets (5-year summary)
Total liabilities¥18.5bnat 2024-02-29Cons.Liabilities
Total liabilities¥16.4bnat 2023-05-31Cons.Liabilities
Net assets / equity¥8.0bnat 2024-02-29Cons.Net assets
Net assets / equity¥7.0bnat 2023-05-31Cons.Net assets
Net assets / equity¥6.8bnat 2023-02-28Cons.Net assets (5-year summary)
Cash and deposits¥5.2bnat 2024-02-29Cons.Cash and deposits
Cash and deposits¥4.7bnat 2023-05-31Cons.Cash and deposits
EPS (basic)¥17.222023-06-01 → 2024-02-29Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥-8.422023-12-01 → 2024-02-29dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥35.452022-06-01 → 2023-05-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥22.242022-06-01 → 2023-02-28Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥14.452022-12-01 → 2023-02-28dCons.Basic earnings loss per share (5-year summary)
EPS (diluted)¥16.482023-06-01 → 2024-02-29Cons.Diluted earnings per share (5-year summary)
EPS (diluted)¥26.892022-06-01 → 2023-05-31Cons.Diluted earnings per share (5-year summary)
EPS (diluted)¥16.892022-06-01 → 2023-02-28Cons.Diluted earnings per share (5-year summary)
Equity ratio29.0%at 2024-02-29Cons.Equity to asset ratio (5-year summary)
Equity ratio28.5%at 2023-05-31Cons.Equity to asset ratio (5-year summary)
Equity ratio28.4%at 2023-02-28Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 44
SegmentItemPeriodValue
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2023-06-01 → 2024-02-29¥593m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2023-06-01 → 2024-02-29¥593m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2023-06-01 → 2024-02-29¥5m
Reconciling Itemsreconcilingsegment profit2023-06-01 → 2024-02-29−¥250m
jpcrp040300-q3r_E05379-000Cosmetic Drug And Convenience Storereportable segmentrevenue2023-06-01 → 2024-02-29¥6.2bn
jpcrp040300-q3r_E05379-000Cosmetic Drug And Convenience Storereportable segmentrevenue external2023-06-01 → 2024-02-29¥6.2bn
jpcrp040300-q3r_E05379-000Cosmetic Drug And Convenience Storereportable segmentsegment profit2023-06-01 → 2024-02-29−¥45m
jpcrp040300-q3r_E05379-000Custody Of Medical Documentsreportable segmentrevenue2023-06-01 → 2024-02-29¥456m
jpcrp040300-q3r_E05379-000Custody Of Medical Documentsreportable segmentrevenue external2023-06-01 → 2024-02-29¥456m
jpcrp040300-q3r_E05379-000Custody Of Medical Documentsreportable segmentsegment profit2023-06-01 → 2024-02-29¥33m
jpcrp040300-q3r_E05379-000Dispensing Pharmacyreportable segmentrevenue2023-06-01 → 2024-02-29¥33.1bn
jpcrp040300-q3r_E05379-000Dispensing Pharmacyreportable segmentrevenue external2023-06-01 → 2024-02-29¥33.1bn
jpcrp040300-q3r_E05379-000Dispensing Pharmacyreportable segmentsegment profit2023-06-01 → 2024-02-29¥1.0bn
jpcrp040300-q3r_E05379-000Medical Mallreportable segmentrevenue2023-06-01 → 2024-02-29¥378m
jpcrp040300-q3r_E05379-000Medical Mallreportable segmentrevenue external2023-06-01 → 2024-02-29¥378m
jpcrp040300-q3r_E05379-000Medical Mallreportable segmentsegment profit2023-06-01 → 2024-02-29¥83m
—segment totalrevenue2023-06-01 → 2024-02-29¥40.1bn
—segment totalrevenue external2023-06-01 → 2024-02-29¥40.1bn
—segment totalsegment profit2023-06-01 → 2024-02-29¥1.1bn
Total Of Reportable Segments And Otherssegment totalrevenue2023-06-01 → 2024-02-29¥40.7bn
Total Of Reportable Segments And Otherssegment totalrevenue external2023-06-01 → 2024-02-29¥40.7bn
Total Of Reportable Segments And Otherssegment totalsegment profit2023-06-01 → 2024-02-29¥1.1bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2022-06-01 → 2023-02-28¥573m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2022-06-01 → 2023-02-28¥573m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2022-06-01 → 2023-02-28¥37m
Reconciling Itemsreconcilingsegment profit2022-06-01 → 2023-02-28−¥226m
jpcrp040300-q3r_E05379-000Cosmetic Drug And Convenience Storereportable segmentrevenue2022-06-01 → 2023-02-28¥5.8bn
jpcrp040300-q3r_E05379-000Cosmetic Drug And Convenience Storereportable segmentrevenue external2022-06-01 → 2023-02-28¥5.8bn
jpcrp040300-q3r_E05379-000Cosmetic Drug And Convenience Storereportable segmentsegment profit2022-06-01 → 2023-02-28−¥170m
jpcrp040300-q3r_E05379-000Custody Of Medical Documentsreportable segmentrevenue2022-06-01 → 2023-02-28¥485m
jpcrp040300-q3r_E05379-000Custody Of Medical Documentsreportable segmentrevenue external2022-06-01 → 2023-02-28¥485m
jpcrp040300-q3r_E05379-000Custody Of Medical Documentsreportable segmentsegment profit2022-06-01 → 2023-02-28¥56m
jpcrp040300-q3r_E05379-000Dispensing Pharmacyreportable segmentrevenue2022-06-01 → 2023-02-28¥31.5bn
jpcrp040300-q3r_E05379-000Dispensing Pharmacyreportable segmentrevenue external2022-06-01 → 2023-02-28¥31.5bn
jpcrp040300-q3r_E05379-000Dispensing Pharmacyreportable segmentsegment profit2022-06-01 → 2023-02-28¥1.1bn
jpcrp040300-q3r_E05379-000Medical Mallreportable segmentrevenue2022-06-01 → 2023-02-28¥378m
jpcrp040300-q3r_E05379-000Medical Mallreportable segmentrevenue external2022-06-01 → 2023-02-28¥378m
jpcrp040300-q3r_E05379-000Medical Mallreportable segmentsegment profit2022-06-01 → 2023-02-28¥70m
—segment totalrevenue2022-06-01 → 2023-02-28¥38.2bn
—segment totalrevenue external2022-06-01 → 2023-02-28¥38.2bn
—segment totalsegment profit2022-06-01 → 2023-02-28¥1.1bn
Total Of Reportable Segments And Otherssegment totalrevenue2022-06-01 → 2023-02-28¥38.7bn
Total Of Reportable Segments And Otherssegment totalrevenue external2022-06-01 → 2023-02-28¥38.7bn
Total Of Reportable Segments And Otherssegment totalsegment profit2022-06-01 → 2023-02-28¥1.1bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 396
ItemContextValueUnit
Non controlling interestsCurrentQuarterInstant81000000JPY
Net assetsPrior1YearInstant6987000000JPY
Net assetsCurrentQuarterInstant7954000000JPY
Liabilities and net assetsPrior1YearInstant23421000000JPY
Liabilities and net assetsCurrentQuarterInstant26425000000JPY
Net salesPrior1YTDDuration38730000000JPY
Net salesCurrentYTDDuration40674000000JPY
Cost of salesPrior1YTDDuration32717000000JPY
Cost of salesCurrentYTDDuration34219000000JPY
Gross profitPrior1YTDDuration6013000000JPY
Gross profitCurrentYTDDuration6455000000JPY
Selling general and administrative expensesPrior1YTDDuration5116000000JPY
Selling general and administrative expensesCurrentYTDDuration5592000000JPY
Operating incomePrior1YTDDuration896000000JPY
Operating incomeCurrentYTDDuration863000000JPY
Interest income noiPrior1YTDDuration1000000JPY
Interest income noiCurrentYTDDuration0JPY
Dividends income noiPrior1YTDDuration1000000JPY
Dividends income noiCurrentYTDDuration0JPY
Commission fee noiPrior1YTDDuration20000000JPY
Commission fee noiCurrentYTDDuration13000000JPY
Rent income noiPrior1YTDDuration12000000JPY
Rent income noiCurrentYTDDuration12000000JPY
Other noiPrior1YTDDuration21000000JPY
Other noiCurrentYTDDuration11000000JPY
Non operating incomePrior1YTDDuration57000000JPY
Non operating incomeCurrentYTDDuration39000000JPY
Interest expenses noePrior1YTDDuration40000000JPY
Interest expenses noeCurrentYTDDuration42000000JPY
Commission fee noePrior1YTDDuration8000000JPY
Commission fee noeCurrentYTDDuration42000000JPY
Rent cost noePrior1YTDDuration8000000JPY
Rent cost noeCurrentYTDDuration6000000JPY
Other noePrior1YTDDuration4000000JPY
Other noeCurrentYTDDuration10000000JPY
Non operating expensesPrior1YTDDuration62000000JPY
Non operating expensesCurrentYTDDuration102000000JPY
Ordinary incomePrior1YTDDuration890000000JPY
Ordinary incomeCurrentYTDDuration799000000JPY
Gain on sales of noncurrent assets eiPrior1YTDDuration1000000JPY
Gain on sales of noncurrent assets eiCurrentYTDDuration0JPY
Reversal of provision for loss on store closing eiPrior1YTDDuration16000000JPY
Reversal of provision for loss on store closing eiCurrentYTDDuration－JPY
Subsidy eiPrior1YTDDuration61000000JPY
Subsidy eiCurrentYTDDuration41000000JPY
Gain on sales of investment securities eiPrior1YTDDuration－JPY
Gain on sales of investment securities eiCurrentYTDDuration19000000JPY
Extraordinary incomePrior1YTDDuration80000000JPY
Extraordinary incomeCurrentYTDDuration61000000JPY
Loss on sales of noncurrent assets elPrior1YTDDuration5000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2023-05-31pass rounding
balance sheet identityconsolidated 2024-02-29pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2023-05-31pass
statement vs summary · net assetsconsolidated 2024-02-29pass
statement vs summary · net income attributable to parentconsolidated 2022-06-01/2023-02-28pass
statement vs summary · net income attributable to parentconsolidated 2023-06-01/2024-02-29pass
statement vs summary · revenueconsolidated 2022-06-01/2023-02-28pass
statement vs summary · revenueconsolidated 2023-06-01/2024-02-29pass
statement vs summary · total assetsconsolidated 2023-05-31pass
statement vs summary · total assetsconsolidated 2024-02-29pass